Findings

What do systematic reviews say?

5 questions · 5 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 40%GRADE not reported 0 · 0%Very low 1 · 20%Low 1 · 20%Moderate 0 · 0%High 1 · 20%

Short protocol vs stop short protocol

Live birth or ongoing pregnancy · women undergoing pituitary suppression in assisted reproduction

The review found no eligible studies for this question.

1 finding from 1 review

Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Short protocol vs stop short protocol

Clinical pregnancy rate · women undergoing pituitary suppression in assisted reproduction

Short protocol showed no clear difference in clinical pregnancies per woman randomised compared with stop short protocol (low certainty).

1 finding from 1 review

Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction 2015 · Cochrane Headline outcomes only
OR 0.59 [0.3, 1.17]
1 study · 230 participants
Low

SHORT vs ultrashort protocol

Live birth or ongoing pregnancy · women undergoing pituitary suppression in assisted reproduction

The review found no eligible studies for this question.

1 finding from 1 review

Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SHORT vs ultrashort protocol

Clinical pregnancy rate · women undergoing pituitary suppression in assisted reproduction

It is very uncertain whether short changes clinical pregnancies per woman randomised compared with ultrashort protocol (very low certainty).

1 finding from 1 review

Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction 2015 · Cochrane Headline outcomes only
OR 1.33 [0.47, 3.81]
1 study · 82 participants
Very low

Anticholinergic and short‐acting beta2‐agonists vs B2‐agonists alone

Hospital admissions · children with initial treatment of acute asthma

Anticholinergic and short‐acting beta2‐agonists leads to lower primary outcome: hospital admissions hospital admissions compared with beta2‐agonists alone (all protocols) (high certainty).

1 finding from 1 review

Combined inhaled anticholinergics and short‐acting beta₂‐agonists for initial treatment of acute asthma in children 2013 · Cochrane Headline outcomes only
RR 0.73 [0.63, 0.85]
19 studies · 2497 participants
High